Study of PIT565 in relapsed and/or refractory B-cell malignancies

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-507430-25-00

Acronym

CPIT565A12101

Enrollment

Registered

2024-02-14

Start date

2022-10-03

Completion date

2026-01-09

Last updated

2026-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Relapsed and/or refractory B-cell Non-Hodgkin lymphoma (R/R B-NHL) and relapsed and/or refractory B-cell acute lymphoblastic leukemia (R/R B-ALL)

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, France, Italy, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026